BGI Genomics and Colombian National Cancer Institute Collaborate to enhance cancer detection and prevention

On October 2, 2023, BGI Genomics signed a Memorandum of Understanding (MoU) with the Colombian National Cancer Institute (INC or Instituto Nacional de Cancerologia).

New deep learning algorithm predicts effects of rare genetic variants

Whether we are predisposed to particular diseases depends to a large extent on the countless variants in our genome.

September 25, 2024

Arcturus Therapeutics handed $115M from Japanese government to develop production site

San Diego-based RNA biotech Arcturus Therapeutics’ manufacturing operations in Japan have been given a financial boost from the local government. Arcalis Co., Ltd., its production

August 15, 2023

FDA approves AstraZeneca’s FASENRA for asthma in children

Share this article AstraZeneca’s FASENRA is indicated for administration as subcutaneous injection. Credit: Melnikov Dmitriy / Shutterstock.com. The US Food and Drug Administration (FDA) has

April 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.